# ITIL-168 in Advanced Solid Tumors

> **NCT05393635** · PHASE1 · WITHDRAWN · sponsor: **Instil Bio**

## Conditions studied

- Cervical Cancer
- Head and Neck Squamous Cell Carcinoma
- Non-small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** ITIL-168

## Key facts

- **NCT ID:** NCT05393635
- **Lead sponsor:** Instil Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-08
- **Primary completion:** 2022-12-08
- **Final completion:** 2022-12-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** business decision
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05393635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05393635, "ITIL-168 in Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05393635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*